Regulators Turn Focus To Mergers & Acquisitions Mega DealsGuest Post
Regulators Turn Focus To Mergers & Acquisitions Mega Deals by Bryan Adams, FactSet
Recently US regulators have forced a re-assessment of two major mergers & acquisitions deals: Pfizer's $194 billion combination with Allergan and Halliburton's $39 billion takeover of Baker Hughes. Rumors of potential action from the US Treasury and the Department of Justice (DoJ) surfaced in the media on April 4 . . .
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.